Haisco plans A-share private placement for 2025

Haisco Pharmaceutical Group (SZSE:002653) has announced its intention to conduct a private placement of A-shares in 2025. The decision was reached during the company's Fifth Board of Directors' 24th meeting and Fifth Board of Supervisors' 13th meeting on February 27, 2025. The offering is subject to approval by shareholders, the Shenzhen Stock Exchange, and the China Securities Regulatory Commission, and the company acknowledges the inherent uncertainties involved. Haisco has committed that neither it nor any related parties will provide financial assistance or compensation to investors participating in the subscription. Furthermore, the company affirmed that it will not guarantee minimum returns or engage in practices that effectively ensure returns.